Bailey v. United States

40 Fed. Cl. 449, 1998 U.S. Claims LEXIS 23, 1998 WL 74216
United States Court of Federal Claims·Decided February 10, 1998·No. No. 96-666C·Published·Cited by 8 cases

Opinion

OPINION

HORN, Judge.

The above-captioned case is before the court on the defendant’s motion to dismiss pursuant to Rule 12(b)(1) of the Rules of the United States Court of Federal Claims (RCFC) for lack of subject matter jurisdiction or, in the alternative, pursuant to RCFC 12(b)(4) for failure to state a claim upon which relief may be granted. The plaintiff filed a complaint1 against the United States in this court which alleges that the plaintiff entered into an oral contract with the defendant for transfer to the plaintiff of 602,000 shares of Biochem Pharma stock that was previously owned by Claude Luis Duboc, a client who the plaintiff was defending in a criminal matter. This stock allegedly had been purchased with proceeds from Mr. Duboc’s drug trafficking activities. The plaintiff alleges that the government agreed not to seek forfeiture of this stock, which, according to the plaintiff, was transferred to the plaintiffs “account unconditionally and in fee simple.” In his opposition to the defendant’s motion to dismiss, the plaintiff further alleges that “[a]t the time the agreement was entered into between Bailey and the Government, there were no discussions of any kind concerning Bailey’s serving in any kind of trustee capacity with respect to the stock.” According to the plaintiff, he “agreed to accept the said stock as the source of various fees and expenses in connection with the Duboc case, in lieu of the cash previously offered or other form of payment.” The plaintiff claims that the defendant breached this oral contract by later seeking forfeiture of the stock.

The defendant, in its motion to dismiss, states that the plaintiffs complaint should be dismissed because it fails to identify a basis for this court’s jurisdiction pursuant to the Tucker Act, 28 U.S.C. § 1491 (1994), as amended by Act of October 19, 1996, 28 U.S.C.A. § 1491 (1997). Specifically, the defendant alleges that the Department of Justice officials with whom the plaintiff claims he reached an agreement lacked the requisite authority necessary to bind the United States. The defendant also argues that Mr. Bailey cannot prevail in the above-captioned case because he is attempting to relitigate [451] claims that were resolved previously by the United States District Court in United States v. Claude Luis Duboc, Case No. GCR 94-01009-MMP, United States District Court for the Northern District of Florida, Gaines-ville Division. In the plaintiff’s opposition to the defendant’s motion to dismiss, he states that, assuming the truth of the facts alleged in the complaint, he has established a breach of contract claim upon which relief can be granted and, thus, the complaint should not be dismissed. The plaintiff further argues that he is seeking a remedy under the Tucker Act in this court which was not available in the District Court and, therefore, that the doctrine of claim preclusion does not apply.

FACTS

The plaintiff, F. Lee Bailey, is an attorney who is licensed to practice in both Florida and Massachusetts. In March 1994, he was retained to represent Claude Luis Duboc who had been charged with international drug importation and money laundering in the matter of United States v. Claude Luis Duboc, Case No. GCR 94-01009-MMP, United States District Court for the Northern District of Florida, Gainesville Division. The plaintiff informed members of the United States Attorney’s Office for the Northern District of Florida that Mr. Duboc was willing to negotiate a plea of guilty.

According to the complaint, the government’s focus then became the forfeiture and repatriation of Mr. Duboc’s property, which was estimated to be worth between $50,000,-000.00 and $100,000,000.00. Much of Mr. Duboc’s property, however, was located outside of the United States and included securities and cash in Luxembourg, real estate in Hong Kong, numerous vehicles, a yacht, and two houses in France. The houses in France required substantial repairs and maintenance in order to realize their maximum value at sale. In addition to the repairs, there also were a number of other necessary expenses associated with Mr. Duboc’s property, including taxes, the cost of staff, overdue debts to tradespersons, and maintenance costs.

The plaintiff alleges that he had discussions with the United States Attorney’s Office about the costs associated with the maintenance, liquidation and repatriation of the overseas property, and the attorney’s fees and legal expenses associated with the representation of Mr. Duboc. According to the plaintiff, “[t]he government prosecutors became concerned that they would need assistance with the repatriation of Duboc’s assets and asked Bailey to take on the responsibility of repatriating Duboc’s overseas assets. Bailey agreed to the assignment.”

According to the complaint, on or about April 26, 1994, the plaintiff had a private meeting with Assistant United States Attorney (AUSA) Gregory R. Miller who offered to unconditionally transfer to the plaintiff one of Mr. Duboc’s Luxembourg cash accounts, which contained approximately $3,500,000.00, from which the plaintiffs claims for “compensation for his services would be paid.” Mr. Bailey alleges that AUSA Miller “on behalf of the United States” agreed to exempt this account from any forfeiture claim by the government.

Mr. Duboc also owned 602,000 shares of Biochem Pharma stock, a Canadian pharmaceutical company that is publicly traded on the NASDAQ stock exchange. The plaintiff states that during the course of a meeting, on April 26, 1994, United States Drug Enforcement Special Agent Carl Lilly recommended that, instead of transferring the Luxembourg cash account to the plaintiff, it would be more advantageous to all of the parties to transfer the shares of Biochem Pharma stock to the plaintiff. According to the plaintiff, Special Agent Lilly suggested this plan because, under the applicable statutes, the government could not hold the stock and would have to sell it immediately upon forfeiture in one block, probably destroying the value of the stock and diminishing the potential yield to the United States.

The plaintiff also alleges in his complaint that at a private conference between Mr. Bailey and AUSA Miller, who, according to the plaintiff, was “acting on behalf of the United States,” the plaintiff was told that “Bailey would have the right to sell any and all of the shares of Biochem Pharma at any time, and in any fashion, Bailey chose,” but that “if the Biochem Pharma stock were to decrease in value, there would be no other [452] source from which Bailey could be compensated for all of his services and reimbursed for his expenses.” The plaintiff states that he agreed to accept the stock instead of the money in the Luxembourg account as the source of his fees and expenses. The plaintiff alleges that the parties understood that the plaintiff bore the risk of loss if the stock price decreased, but that he would have the benefit of any increase if the stock price rose.

Free access — add to your briefcase to read the full text and ask questions with AI

Bailey v. United States, 40 Fed. Cl. 449, 1998 U.S. Claims LEXIS 23, 1998 WL 74216 (uscfc 1998).

40 Fed. Cl. 449 (Bailey v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Mendez v. United States
121 Fed. Cl. 370 (Federal Claims, 2015)
Huntington Promotional & Supply, LLC v. United States
114 Fed. Cl. 760 (Federal Claims, 2014)
Bailey v. Comm'r
2012 T.C. Memo. 96 (U.S. Tax Court, 2012)
Gary v. United States
67 Fed. Cl. 202 (Federal Claims, 2005)
Bailey v. United States
54 Fed. Cl. 459 (Federal Claims, 2002)
United States v. Bailey
175 F.3d 966 (Eleventh Circuit, 1999)